{"anticipatedPostingDate":"2029-05","denomUnitsSelected":"Participants","description":"Outcome data will be provided after the study is completed.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to Progressive Disease or Death due to any cause (Estimated up to 12 months)","title":"To Assess the Preliminary Anti-Tumor Activity of LOXO-292 in Pediatric Participants With Tumors Harboring an Activating RET Alteration as Determined by ORR Based on RECIST v1.1","type":"SECONDARY"}